tirzepatide surmount-1 trial weight loss non-diabetic nondiabetic SURMOUNT 1 // Three-Year Obesty & Diabetes Prevention Outcomes tirzepatide trial obesity without diabetes

"Im happier, Im more energetic, and there's no question I'm healthier."

Most GLP-1 pens contain only a small amount of liquid medication and are well below the 3.4 oz limit individually, but I recommend declaring any medications and supplies during screening to be safe," says Woodcock

These reactions are unrelated to time of day but can be minimized through proper injection technique, site rotation, and ensuring medication reaches room temperature before administration

Expired medication complaints, while not the majority experience, represent a serious quality concern

Lilly is positioning the drug as a convenient oral alternative to injectable GLP-1 medicines